FDA Panel Votes on Tenapanor for Hyperphosphatemia in CKD
For patients who tolerated and remained on therapy, the average treatment effect on serum phosphorus was about -0.7mg/dL.
Diagnosis & Disease Information
Kidney Function Declines More Slowly With SGLT2 Inhibitor
Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.
Empagliflozin Cuts Risk of Kidney Disease Progression, CV Death in CKD Patients
The EMPA-KIDNEY trial enrolled more than 6600 patients 18 years of age and older with CKD at risk of kidney disease progression.
Anemia Increases Dementia Risk in CKD
The association is revealed in a study of more 444,000 US veterans with new-onset chronic kidney disease.
Finerenone May Protect Against Pneumonia and COVID-19
Finerenone, a mineralocorticoid receptor antagonist, may exert anti-inflammatory and anti-fibrotic effects, according to investigators.
FDA Panel Votes on Daprodustat for Anemia of Chronic Kidney Disease
The NDA was supported by data from the ASCEND clinical program, which included dialysis and nondialysis patients.
COVID-19 Vaccines Reduce Risk of Severe Outcomes in CKD
Vaccination decreased the risk for COVID-related hospitalization and death, according to a retrospective study.
Study Finds Low Nephrology Referral Rate for High-Risk CKD
Even patients at the highest risk for kidney failure had inadequate nephrology referral, a study found.
Paxlovid Use for COVID-19 May Be Feasible in Advanced CKD
Nirmatrelvir/ritonavir is not current recommended for patients with CKD stage 4 or 5, but low-dose regimens could avoid adverse events, according to the authors of a recent editorial.
Ultra-Processed Foods May Up CKD Risk
Sugar-sweetened beverages are a frequently consumed ultra-processed food group.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...